Company intelligence / Profile preview
Zhejiang Shengchuang Precision Medical Technology
Zhejiang, Chinasanch-lab.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Zhejiang Shengchuang Precision Medicine Technology is a private Chinese biotech company focused on developing mesenchymal stem cell therapies, with its lead program in Phase 1 clinical trials targeting COVID-19. The company’s main therapeutic focus includes infectious and respiratory diseases. No published clinical results are available as of the latest update.
- Therapeutic areas
- PulmonologyInfectious Diseases
- Modalities
- Mesenchymal stem cell therapy
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Zhejiang Shengchuang Precision Medical Technology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zhejiang Shengchuang Precision Medical Technology.